FMC

+ Watchlist + Portfolio

FMC Corp.

GridBrain — Sign in

GridSentinel — Sign in

GridAegis — Sign in

Key Metrics

Previous Close: $10.81
52-Week Range: $9.95 – $40.84
Market Cap: $1.36B
P/E (TTM): —
EPS (TTM): -21.63
Dividend Yield: 2.96%

Advanced Metrics

Price/Book: 0.83
PEG Ratio: 1.55
Return on Equity: -88.38%
Return on Assets: 0.58%
Gross Margin: 31.93%
Operating Margin: 11.83%
Profit Margin: -84.83%
Current Ratio: 1.99
Debt/Equity: 2.65
Total Debt: $4.40B
Free Cash Flow: $165.64M
Revenue Growth: -17.50%
Earnings Growth: —
Enterprise Value: $5.31B

FMC Income statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Revenue	$5.80B	$4.49B	$4.25B	$3.47B
Cost of Revenue	$3.48B	$2.66B	$2.60B	$2.18B
Gross Profit	$2.33B	$1.83B	$1.65B	$1.28B
Research & Development	$314.20M	$328.80M	$278.00M	$266.10M
Selling, General & Admin	$775.20M	$734.30M	$644.60M	$684.90M
Operating Expenses	$1.09B	$1.06B	$922.60M	$951.00M
Operating Income	$1.24B	$767.90M	$726.30M	$332.00M
EBITDA	$1.31B	$721.70M	$664.60M	-$1.47B
Pretax Income	$983.90M	$300.20M	$252.50M	-$1.89B
Income Tax	$145.20M	-$1.12B	-$150.90M	$314.20M
Net Income	$736.50M	$1.32B	$341.10M	-$2.24B
Diluted EPS	5.81	10.53	2.72	-17.88
Diluted Shares	126.70M	125.50M	125.40M	125.16M

FMC Balance Sheet statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Cash & Equivalents	$572.00M	$302.40M	$357.30M	$584.50M
Receivables	$3.04B	$2.95B	$3.17B	$2.36B
Inventory	$1.65B	$1.72B	$1.20B	$1.22B
Current Assets	$5.44B	$5.13B	$4.96B	$4.96B
Total Assets	$11.17B	$11.93B	$11.65B	$9.69B
Current Liabilities	$3.80B	$3.38B	$3.02B	$3.76B
Long-Term Debt	$2.73B	$3.02B	$3.03B	$2.77B
Total Debt	$3.42B	$4.11B	$3.50B	$4.20B
Total Liabilities	$7.77B	$7.49B	$7.14B	$7.59B
Retained Earnings	$5.56B	$6.59B	$6.64B	$4.17B
Shareholders' Equity	$3.38B	$4.41B	$4.49B	$2.07B
Working Capital	$1.64B	$1.74B	$1.94B	$1.20B
Net Debt	$2.70B	$3.66B	$3.01B	$3.49B

FMC Cash Flow statement, annual periods, in USD
USD	FY2022	FY2023	FY2024	FY2025
Operating Cash Flow	$582.40M	-$386.40M	$671.10M	-$80.20M
Capital Expenditure	-$142.30M	-$133.90M	-$67.90M	-$96.30M
Free Cash Flow	$440.10M	-$520.30M	$603.20M	-$176.50M
Depreciation & Amortisation	$169.40M	$184.30M	$176.30M	$173.60M
Stock-Based Compensation	$24.20M	$25.90M	$23.80M	$24.00M
Investing Cash Flow	-$266.40M	-$154.40M	$263.60M	-$99.70M
Financing Cash Flow	-$237.40M	$331.50M	-$870.10M	$386.00M
Dividends Paid	-$267.50M	-$290.50M	-$290.60M	-$291.30M
Share Repurchases	-$108.90M	-$81.20M	-$2.30M	-$1.80M
Net Change in Cash	$78.60M	-$209.30M	$64.60M	$206.10M

FMC Income statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Revenue	$1.05B	$542.20M	$1.08B	$758.60M	$867.10M
Cost of Revenue	$644.20M	$413.30M	$652.20M	$512.00M	$525.00M
Gross Profit	$406.30M	$128.90M	$431.10M	$246.60M	$342.10M
Research & Development	$66.40M	$63.30M	$67.70M	$65.50M	$60.40M
Selling, General & Admin	$176.80M	$167.40M	$168.70M	$185.10M	$179.10M
Operating Expenses	$243.20M	$230.70M	$236.40M	$250.60M	$239.50M
Operating Income	$163.10M	-$101.80M	$194.70M	-$4.00M	$102.60M
EBITDA	$163.20M	-$358.50M	-$1.38B	-$42.40M	-$81.90M
Pretax Income	$58.80M	-$466.00M	-$1.48B	-$149.20M	-$194.30M
Income Tax	$14.40M	$82.20M	$204.10M	$112.10M	-$1.50M
Net Income	$66.70M	-$569.30M	-$1.72B	-$281.30M	-$186.60M
Diluted EPS	0.53	-4.52	-13.74	-2.25	-1.49
Diluted Shares	125.57M	125.20M	125.20M	125.28M	125.40M

FMC Balance Sheet statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Cash & Equivalents	$438.20M	$497.70M	$584.50M	$390.90M	$476.60M
Receivables	$3.08B	$2.33B	$2.36B	$2.24B	$2.07B
Inventory	$1.40B	$1.38B	$1.22B	$1.24B	$1.21B
Current Assets	$5.47B	$5.57B	$4.96B	$4.90B	$4.73B
Total Assets	$12.30B	$12.08B	$9.69B	$9.42B	$9.14B
Current Liabilities	$3.57B	$3.99B	$3.76B	$3.81B	$2.38B
Long-Term Debt	$3.27B	$3.27B	$2.77B	$2.77B	$3.95B
Total Debt	$4.16B	$4.54B	$4.20B	$4.53B	$4.28B
Total Liabilities	$7.87B	$8.28B	$7.59B	$7.57B	$7.48B
Retained Earnings	$6.54B	$5.90B	$4.17B	$3.88B	$3.68B
Shareholders' Equity	$4.40B	$3.77B	$2.07B	$1.82B	$1.64B
Working Capital	$1.89B	$1.58B	$1.20B	$1.09B	$2.35B
Net Debt	$3.73B	$4.04B	$3.49B	$4.14B	$3.80B

FMC Cash Flow statement, quarterly periods, in USD
USD	Q2 2025	Q3 2025	Q4 2025	Q1 2026	Q2 2026
Operating Cash Flow	$49.50M	-$208.20M	$636.80M	-$616.60M	$344.40M
Capital Expenditure	-$15.00M	-$23.70M	-$26.00M	-$16.60M	-$5.30M
Free Cash Flow	$34.50M	-$231.90M	$610.80M	-$633.20M	$339.10M
Depreciation & Amortisation	$43.40M	$43.40M	$43.10M	$42.00M	$41.10M
Stock-Based Compensation	$6.90M	$6.80M	$6.10M	$3.00M	$7.70M
Investing Cash Flow	-$13.40M	-$33.00M	-$15.30M	-$16.20M	$6.20M
Financing Cash Flow	$76.60M	$303.40M	-$546.10M	$442.30M	-$263.40M
Dividends Paid	-$72.80M	-$72.90M	-$72.90M	-$10.00M	-$10.20M
Share Repurchases	$0.00	-$300.00K	-$100.00K	-$900.00K	-$300.00K
Net Change in Cash	$112.70M	$62.20M	$75.40M	-$190.50M	$87.20M

Market Snapshot

About

FMC Corporation is a global agricultural sciences company providing crop protection chemicals, plant health products, and professional pest control solutions. The company's product portfolio includes insecticides, herbicides, fungicides, and biological solutions used by farmers to protect crops and improve yields across major agricultural markets worldwide. FMC operates research and development facilities, manufacturing plants, and distribution networks across North America, Latin America, Europe, the Middle East, Africa, and Asia. The company serves row crop, specialty crop, and turf/ornamental markets with both proprietary active ingredients and formulated products. FMC is headquartered in Philadelphia, Pennsylvania.